< Back to all clusters
[HEALTH] · United States, Ireland · 4 sources

started · updated

Vitamin D Linked to Lower Tau Protein Levels in Midlife Study

Researchers analyzing data from the Framingham Heart Study followed 793 dementia‑free adults for more than 16 years. Participants had their blood vitamin D levels measured at an average age of 39, and about 430 of them later underwent PET brain scans. The scans showed that higher midlife vitamin D concentrations were associated with significantly lower accumulation of toxic tau proteins, a key early marker of Alzheimer’s disease. No relationship was found between vitamin D status and amyloid‑beta deposits.

The observational study, conducted by scientists at the University of Galway and published in Neurology Open Access (2026), emphasizes that the findings indicate an association, not causation. It is the first large‑scale investigation to focus on younger, cognitively healthy adults, suggesting that maintaining adequate vitamin D levels in midlife could offer a window for preventive strategies. The authors call for clinical trials to determine whether long‑term vitamin D supplementation can reduce tau buildup or lower dementia risk.

Entities

Alzheimer's disease · Emer McGrath · Framingham Heart Study · Framingham Heart Study · University of Galway · Vitamin D · tau protein

Claims

What the coverage asserts, and how many sources carry each claim.